Premenstrual dysphoric disorders in women of Russian Federation and risk factors for their development. Epidemiological study of1,326 women
https://doi.org/10.33667/2078-5631-2019-1-2(377)-43-46
Abstract
The epidemiology of premenstrual dysphoric disorders (PMDD) and the risk factors for PMDD in women of the Russian Federation are still not fully resolved. Objective: to assess the prevalence of PMDD among women in the Russian Federation and to identify risk factors for PMDD. Materials and methods. An anonymous questioning using the questionnaire was carried out by 1326 women of the reproductive period of different regions of the Russian Federation: Moscow (880), Ural (150), Rostov (146) and Novosibirsk (150) regions. Inclusion criteria were: age of 15-45 years, regular menstrual cycle of 25-35 days, lack of psychiatric diagnoses in history. The results. It was found that 15.6 % of Russian women meet the criteria for PMDD. The primary age of the first appearance of PMDD symptoms is 15-19 years. The statistically significant risks of developing PMDD are ages 15-24 years, education at a higher education institution, lack of regular sexual life, history of neurocirculatory dystonia, complication of heredity in neuropsychiatric diseases and premenstrual syndrome, painful periods and complications in childbirth or abortion. Conclusions: the high prevalence of PMDD (15.6 %) in young women of the reproductive period, the presence of psychosocial and biological risk factors for PMDD requires the development of a modified tool for the early diagnosis of PMDD for general practitioners, obstetrician gynecologists, and psychiatrists.
About the Authors
K. B. Loginova
Russian National Research Medical University n.a. N. I. Pirogov
Russian Federation
Russian Federation
G. M. Dyukova
Clinical Scientific and Practical Centre n.a. A. S. Loginov
Russian Federation
Russian Federation
Yu. E. Dobrokhotova
Russian National Research Medical University n.a. N. I. Pirogov
Russian Federation
Russian Federation
A. B. Danilov
First Moscow State Medical University n.a. I. M. Sechenov
Russian Federation
Russian Federation
References
1. American Psychiatric Assn. Diagnostic and statistical manual of mental disorders (5th ed.) 5th ed American Psychiatric Publishing; Arlington: 2013.
2. Steiner M, Macdougall M, Brown E. The premenstrual symptoms screening tool (PSST) for clinicians. Arch Womens Ment Health 2003. 6:203-9.
3. Sveindottir H, Backstrom T. Prevalence of menstrual cycle symptom cyclicity and premenstrual dysphoric disorder in a random sample of women using and not using oral contraceptives. Acta Obstet Gynecol Scand 2000. 79: 405-13.
4. Wittchen HU, BeckerE, Lieb R, et al. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med. 2002.32: 119-32.
5. Halbreich U, Borenstein J, Pearlstein T, et al. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology 2003.28 (Suppl 3): 1-23 1.
6. Angst J, Sellaro R, Merikangas KR, et al. The epidemiology of perimenstnjal psychological symptoms. Acta PsychiatrScand. 2001. 104: 110-6.
7. Vichnin M., Freeman E. W., Lin H. Et al. Premenstrual Syndrome (PMS) in Adolescents: Severity and Impairment // Journal of Pediatric & Adolescent Gynecology. 2006. N19. P. 397-402.
8. de Carvalho AB, Cardoso TA, Mondin TC et al. Prevalence and factors associated with Premenstrual Dysphoric Disorder A community sample of young adult women.Psychiatry Res. 2018. Jun 26:268:42-45. doi: 10.1016/j.psychres.2018.06.005.
9. Osman OT, Sabr S, Zoubeidi T et al. Prevalence, Severity, and Correlates of Premenstrual Dysphoric Disorder Symptoms Among Women in the Arabian Peninsula // Prim Care Companion CNS Disord. 2017. Jul 6; 19 (4). pii: 17m02112. doi: 10.4088/PCC.17m02112.
10. Czajkowska M, Drosdzol-Cop A, Gatqzka I et al. Menstrual Cycle and the Prevalence of Premenstrual Syndrome/Premenstrual Dysphoric Disorderin Adolescent Athletes. J PediatrAdolesc Gynecol. 2015. Dec; 28 (6): 492-8. doi: 10.1016/j.jpag.2015.02.113.
11. Pearlstein T., Steiner M., Premenstrual dysphoric disorder: burden of illness and treatment update. 2008 J Psychiatry Neurosci 2008; 33 (4): 291-301.
12. Takeda T, Imoto Y, Nagasawa H et al. Premenstrual Syndrome and Premenstrual Dysphoric Disorder in Japanese Collegiate Athletes. // Pediatr Adolesc Gynecol. 2015. Aug; 28 (4): 215-8. doi: 10.1016/j.jpag.2014.07.006. Epub2014 Jul22.
13. Derman O, Kanbur NO, Tokur TE, Kutluk T. Premenstrual syndrome and associated symptoms in adolescentgirls. // Eur J Obstet Gynecol Reprod Biol. 2004. Oct 15; 116 (2): 201-6.
14. Steiner M, Peer M, Palova E et al. The premenstrual symptoms screening tool revised for adolescents (PSST-A): prevalence of severe PMS and premenstrual dysphoric disorder in adolescents. Arch Womens Ment Health. 2011. 14: 77-81.
15. Kitamura M, Takeda T., Koga Sh. et al. Relationship between premenstrual symptoms and dysmenorrhea in Japanese high school students. Arch Womens MentHealth.2012. 15: 131-133 DOI 10.1007/s00737-012-0266-2.
16. Kantero RL, Widholm O. Correlations of menstrual traits between adolescent girls and their mothers. Acta Obstet Gynecol Scand 1971; 14 (suppl 14): 30-6.
17. Hong Jin Pyo, Park Subin, Wang Hee-Ryung. Prevalence, correlates, comorbidities, and suicidal tendencies of premenstrual dysphoric disorder in a nationwide sample of Korean women//Soc Psychiatry Psychiatr Epidemiol. 2012.47: 1937-1945. DOI 10.1007/s00127-012-0509-6.
18. Дюкова Г. М., Голубев В.Л., Погромов А. П., Мнацаканян М. Г. Функциональные расстройства: современные представления о систематике клинических проявлений и патогенезе. (Обзор литературы). Журнал неврологии и психиатрии им. СС Корсакова 2016, Том 116, № 12, стр. 115-120.
19. Pearlstein T. Ptemenstrual Syndrome. In Book Functional Somatic Syndrome: Etiology, Diagnosis, Treatment. Ed. Peter Manu. Cambridge University Press, 1998, p. 80-97.
Review
For citations:
Loginova K.B., Dyukova G.M., Dobrokhotova Yu.E., Danilov A.B. Premenstrual dysphoric disorders in women of Russian Federation and risk factors for their development. Epidemiological study of1,326 women. Medical alphabet. 2019;1(2):43-46. (In Russ.) https://doi.org/10.33667/2078-5631-2019-1-2(377)-43-46
Views:
534
Email this article 